About Cellarity
Cellarity is a Healthcare company based in Cambridge (United States) founded in 2015 by Avak Kahvejian. Developer of drugs to treat various diseases. Cellarity has raised $294 million across 3 funding rounds from investors including BlackRock, Flagship Pioneering and Kyowa Kirin. The company has 117 employees. Its chief executive, as recorded, is Avak Kahvejian. Cellarity offers products and services including Cellarity Platform and Pipeline. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its competitors include Asimov, Metaphore and Evolved By Nature; 3 of its 3 listed competitors have raised funding.
Company details
Cellarity was founded in 2015 in Cambridge, United States, within the biotechnology sector. Single-cell technologies and machine learning are integrated into a platform to digitize and quantify cellular behaviors. Medicines are designed through this approach for applications in hematology, immuno-oncology, metabolism, and respiratory diseases. Operations focus on drug development to address these therapeutic areas.
- Headquarters Cambridge, United States
- Employees 117
- Founders Avak Kahvejian
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website cellarity.com
- Social LinkedIn X
- Total Equity Funding$294M (USD)
in 3 rounds
- Latest Funding Round$121M (USD), Series C
Oct 2022
- InvestorsBlackRock
& 6 more
- Employee Count117
Products & Services of Cellarity
Cellarity offers a comprehensive portfolio of products and services, including Cellarity Platform and Pipeline.
Platform for analyzing omics data to design medicines.
System for developing medicines against cellular dysfunction.
Funding Insights of Cellarity
Cellarity has successfully raised a total of $294M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $121 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $294M
- Total Rounds 3
- Last Round Series C — $121M
- First Round $50M
(Dec 2019)
- Investors Count 7
All 3 funding rounds of Cellarity with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2022 | $121M | Series C | – | – | |
| Feb 2021 | $123M | Series B | – | BlackRock, The Baupost Group | |
| Dec 2019 | $50M | Series A | – | – | – |
7 investors in total: 7 institutional.
Investors in Cellarity
Cellarity has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include BlackRock, Flagship Pioneering and Kyowa Kirin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life sciences-focused venture capital firm | 1999 | flagshippioneering.com | Cambridge, United States | |
Infrastructure and venture capital firm focused on renewable energy, technology, and life science sectors | jimco.com | |||
Developer of biologics for multiple diseases and disorders | 1949 | kyowakirin.com | Chiyoda City, Japan | |
| hanwhaimpact.com | ||||
Diversified investment management firm and private fund focused on debt, equity, and secondary market investments in multiple sectors | 1988 | blackrock.com | New York, United States | |
Conducts long-term value-oriented investments for families, foundations, and institutions. | 1982 | baupost.com | Boston, United States | |
| group.pictet |
Investor details for Cellarity
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cellarity
9 people are tracked at Cellarity (1 in leadership, 7 in board & advisors, 1 in team); the tracked headcount is 117.
| Name | Role | Group |
|---|---|---|
Avak Kahvejian | Founder & CEO | Leadership |
Noubar Afeyan | Co-Founder | Board & advisors |
Sandra Horning | Director | Board & advisors |
Stephen Berenson | Chairman | Board & advisors |
Jim Collins | Board Member | Board & advisors |
Carl P. Decicco | Board Member | Board & advisors |
Ian Estepan | Board Member | Board & advisors |
Gregory Moore | Board Member | Board & advisors |
Fabrice Chouraqui | Board Member | Team |
Complete people profiles for Cellarity
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cellarity
3 dated milestones of Cellarity across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Cellarity is founded.
- Funding First funding round of $50.0M.
- Funding Latest funding round, Series C, of $121.0M.
Competitors of Cellarity
Cellarity has 3 listed competitors in our database, 3 of them funded. They include Asimov, Metaphore and Evolved By Nature.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asimov.com | 2017 | Boston, United States | $209.4M | 87 | Provider of integrated suite for advanced genetic design and manufacturing | |
| metaphorebio.com | 2021 | Cambridge, United States | $50M | Provider of machine language and computational platform for drug discovery | ||
| evolvedbynature.com | 2013 | Medford, United States | $190M | 99 | Digital technology for biomedicinal molecule development in research is utilized. |
Detailed competitors of Cellarity
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cellarity
The website of Cellarity (cellarity.com) receives about 5.8K visits a month and ranks #2,884,812 among all websites worldwide, #3,865 in Biotechnology and Pharmaceuticals.
- Monthly visits5.8K
▲ 8.7% vs previous month
- Unique visitors2.5K
per month
- Global rank#2,884,812
among all websites
- Category rank#3,865
Health · Biotechnology and Pharmaceuticals
- Bounce rate29%
- Pages per visit3.1
- Average visit2 min 18 sec
- DevicesDesktop 40% · Mobile 60%
Websites whose visitors overlap most with Cellarity. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| paratekpharma.com | 100% | 4K | #5,533,702 | View details | |
| praxismedicines.com | 99% | 35.6K | #1,244,570 | View details | |
| ensoma.com | 99% | 2.8K | #4,644,561 | View details | |
| servier.us | 99% | #2,050,491 | View details | ||
| pieris.com | 96% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Cellarity
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Cellarity (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cellarity
Complete news archive for Cellarity
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellarity
Cellarity was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Cellarity is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Avak Kahvejian is the CEO of Cellarity, as recorded in our data. They have also founded this company.
Cellarity is a funded company, having raised a total of $294M across 3 funding rounds to date. The company's 1st funding round was a Series A of $50M, raised on Dec 2019.
Cellarity has 117 employees.
Cellarity was founded in 2015 in Cambridge, United States, within the biotechnology sector. Single-cell technologies and machine learning are integrated into a platform to digitize and quantify cellular behaviors. Medicines are designed through this approach for applications in hematology, immuno-oncology, metabolism, and respiratory diseases. Operations focus on drug development to address these therapeutic areas.
Cellarity's top competitors include Asimov, Metaphore and Evolved By Nature.
Cellarity offers Cellarity Platform and Pipeline.
Cellarity has 7 investors. Key investors include BlackRock, Flagship Pioneering, Kyowa Kirin, Hanwha Impact, and The Baupost Group.